Published: 2017-07-26

Thrombocytopenia during pregnancy: an institutional based prospective study of one year

Anubha Pandey, Roma Singh


Background: Platelets are non-nucleated cellular fragments of megakaryocytes, they play a critical role in haemostasis. Thrombocytopenia, defined as blood platelet count below 150.000/μL is the second leading cause of blood disorders in pregnancy after anemia. It complicates 7 to 10% of all pregnancies. Gestational thrombocytopenia explains 70-80% of all cases of thrombocytopenia in pregnancy. Hypertensive disorders account for approximately 20% and immune thrombocytopenic purpura for about 3-4%. Other etiologies are considered rare in pregnancy.

Methods: The study was conducted in the tertiary institute over a period of one year, from January 2016 to December 2016. The samples of blood were collected from the Antenatal out-patient department and from indoor patients of the department of gynecology and obstetrics of the J.K. Hospital, Bhopal, Madhya Pradesh India.

Results: Maximum number of patients had moderate degree of anemia around 58%. Most of the cases presented during 30-34 weeks of gestation. The most common etiology was gestational thrombocytopenia.

Conclusions: Thrombocytopenia in pregnancy may occur secondary to a variety of causes. Most of these cases occur during specific periods of gestation. Management of pregnant women with platelet disorders requires a multidisciplinary approach and close collaboration between obstetric and hepatologist.


Anemia, Platelets, Pregnancy, Thrombocytopenia

Full Text:



Richard F, Alexandre H. Thrombocytopenia in pregnancy. 2006. Available at Accessed 15 Jan 2011

Perepu U, Rosenstein L. Maternal thrombocytopenia in pregnancy. Proceedings Obstetrics Gynecol. 2013;3(1):6.

Sainio S, Kekomäki R, Riikonon S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand. 2000;79(9):744-9.

Boehlen F, Hohlfeld P, Extermann P, Perneger TV, de Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol. 2000;95(1):29-33.

McCrae KR. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Rev. 2003;17(1):7-14.

Ballem PJ. Hematological problems of pregnancy. Can Fam Physician. 1988;34:2531-7.

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168-86.

Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood 2013;121:38-47.

Brecher G, Cronkite EP. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950;3:365.

Mathews JH, Benjamin S, Gill DS, Smith NA. Pregnancy associated thrombocytopenia definition, incidence and natural history. Acta Hematol. 1990;84:24-9.

Crowther MA, Burrows RF, Ginsberg J, Kelton JG. Thrombocytopenia in pregnancy: Diagnosis, pathogenesis and management. Blood Rev. 1996;10:8-16.

Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermaihu T, Levi I, et al. Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2006;18(1-2):163-8.